Clinical Trials in Miami

Showing 5101-5120 of 11,431 trials

A Study to Assess S-217622 in Participants With Renal Impairment and Healthy Participants

NCT05363215

The objective of this study is to measure the PK, safety, and tolerability of S-217622 in participants with mild, moderate, or severe renal impairment and in those with normal renal function.

Renal Impairment

Shionogi32 participantsStarted Aug 2022

Miami, Florida, United States • Miami, Florida, United States • Orlando, Florida, United States +1 more locations

COMPLETEDPhase 4< 1 mile

The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Eyelid Position, Eye Redness, and Eye Appearance

NCT04831047

The purpose of the research is to see if Upneeq ( oxymetazoline 0.1% ophthalmic solution) has an effect on eyelid position, eye redness, or patient-perceived appearance of the eyes.

Ptosis, EyelidConjunctiva InflamedEye Manifestations

University of Miami114 participantsStarted Jun 2021

Miami, Florida, United States

COMPLETEDPhase 3< 1 mile

Randomized Trial in Adult Participants With Acute Migraines

NCT04571060

The purpose of this study is to test the safety and efficacy of BHV-3500 (zavegepant) versus placebo in the acute treatment of moderate or severe migraine.

Migraine

Pfizer1,978 participantsStarted Oct 2020

Huntsville, Alabama, United States • Mobile, Alabama, United States • Chandler, Arizona, United States +91 more locations

A Study to Assess S-217622 in Participants With Renal Impairment and Healthy Participants

The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Eyelid Position, Eye Redness, and Eye Appearance

Randomized Trial in Adult Participants With Acute Migraines

Find Trials by Condition in Miami

Rapid Diagnostics for HIV and Hepatitis

tPA by Endovascular Administration for the Treatment of Submassive PE Using CDT for the Reduction of Thrombus Burden

A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.

VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study

A Study to Assess the Pharmacokinetic (PK) Comparability of 2 Fixed Subcutaneous (SC) Doses of Aducanumab (BIIB037) With a Single, Weight-Based Intravenous (IV) Dose in Healthy Volunteers

A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS)

Single Ascending Dose Study to Evaluate Pharmacokinetics and Food-Effect in Healthy Volunteers

This is a Trial of MG1-E6E7 With Ad-E6E7 and Atezolizumab in Patients With HPV Associated Cancers

Pilot Testing of Baby Feed: A Web Application for Health Professionals and Parents to Improve Infant Diets

Rifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy (OHE)

Study to Identify and Determine Best Implementation Practices for Injectable Cabotegravir+Rilpivirine in the United States (US)

A Study of TAK-951 to Stop Adults Getting Nausea and Vomiting After Planned Surgery

Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence

A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia

Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)

A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2)

Safety, Tolerability, and Pharmacokinetics of CAL056 Mesylate in Patients With Resistant or Refractory Solid Tumors